| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 3.07e-05 | 13 | 97 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 3.07e-05 | 13 | 97 | 3 | GO:0140829 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 4.62e-05 | 41 | 97 | 4 | GO:0008227 | |
| GeneOntologyMolecularFunction | antiporter activity | 5.76e-05 | 138 | 97 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | carbonate dehydratase activity | 5.94e-05 | 16 | 97 | 3 | GO:0004089 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | HTR1D TAAR2 KIR2DS2 TAAR5 GABBR2 CD200R1 OR10AG1 ADRA2B GPR174 OR6C2 RXFP2 OR56A3 CCR6 ADGRD2 KIR2DL1 KIR2DL3 KIR2DS5 IL4R | 8.04e-05 | 1353 | 97 | 18 | GO:0004888 |
| GeneOntologyMolecularFunction | immune receptor activity | 1.54e-04 | 165 | 97 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 4.98e-04 | 32 | 97 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 4.98e-04 | 32 | 97 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 5.68e-04 | 293 | 97 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | trace-amine receptor activity | 6.42e-04 | 8 | 97 | 2 | GO:0001594 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 7.17e-04 | 83 | 97 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | HTR1D TAAR2 TAAR5 GABBR2 OR10AG1 ADRA2B GPR174 OR6C2 RXFP2 OR56A3 CCR6 ADGRD2 | 1.18e-03 | 884 | 97 | 12 | GO:0004930 |
| GeneOntologyBiologicalProcess | regulation of dipeptide transport | 2.23e-05 | 2 | 98 | 2 | GO:0090089 | |
| GeneOntologyBiologicalProcess | regulation of oligopeptide transport | 2.23e-05 | 2 | 98 | 2 | GO:0090088 | |
| GeneOntologyBiologicalProcess | positive regulation of dipeptide transport | 2.23e-05 | 2 | 98 | 2 | GO:2000880 | |
| GeneOntologyBiologicalProcess | positive regulation of oligopeptide transport | 2.23e-05 | 2 | 98 | 2 | GO:2000878 | |
| GeneOntologyBiologicalProcess | positive regulation of dipeptide transmembrane transport | 2.23e-05 | 2 | 98 | 2 | GO:2001150 | |
| GeneOntologyBiologicalProcess | regulation of dipeptide transmembrane transport | 2.23e-05 | 2 | 98 | 2 | GO:2001148 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 8.58e-05 | 94 | 98 | 5 | GO:0051453 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 1.21e-04 | 101 | 98 | 5 | GO:0030641 | |
| GeneOntologyBiologicalProcess | angiotensin-activated signaling pathway | 1.96e-04 | 24 | 98 | 3 | GO:0038166 | |
| GeneOntologyBiologicalProcess | cellular response to hyperoxia | 2.21e-04 | 5 | 98 | 2 | GO:0071455 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular pH reduction | 2.21e-04 | 5 | 98 | 2 | GO:0032849 | |
| GeneOntologyBiologicalProcess | regulation of pH | 2.70e-04 | 120 | 98 | 5 | GO:0006885 | |
| GeneOntologyCellularComponent | caveolar macromolecular signaling complex | 9.69e-08 | 3 | 97 | 3 | GO:0002095 | |
| GeneOntologyCellularComponent | integrator complex | 1.21e-04 | 21 | 97 | 3 | GO:0032039 | |
| GeneOntologyCellularComponent | basal part of cell | 3.78e-04 | 378 | 97 | 8 | GO:0045178 | |
| HumanPheno | Hypocalcemia | 6.76e-06 | 86 | 29 | 6 | HP:0002901 | |
| Domain | CA2 | 2.61e-05 | 2 | 96 | 2 | IPR018443 | |
| Domain | Carbonic_anhydrase_a-class_CS | 2.80e-05 | 12 | 96 | 3 | IPR018338 | |
| Domain | Carbonic_anhydrase_a-class | 5.73e-05 | 15 | 96 | 3 | IPR023561 | |
| Domain | ALPHA_CA_1 | 5.73e-05 | 15 | 96 | 3 | PS00162 | |
| Domain | Caveolin | 7.82e-05 | 3 | 96 | 2 | IPR001612 | |
| Domain | Caveolin_CS | 7.82e-05 | 3 | 96 | 2 | IPR018361 | |
| Domain | - | 7.82e-05 | 3 | 96 | 2 | 4.10.1130.10 | |
| Domain | Caveolin | 7.82e-05 | 3 | 96 | 2 | PF01146 | |
| Domain | CAVEOLIN | 7.82e-05 | 3 | 96 | 2 | PS01210 | |
| Domain | ALPHA_CA_2 | 8.49e-05 | 17 | 96 | 3 | PS51144 | |
| Domain | Carb_anhydrase | 8.49e-05 | 17 | 96 | 3 | PF00194 | |
| Domain | Carb_anhydrase | 8.49e-05 | 17 | 96 | 3 | SM01057 | |
| Domain | - | 8.49e-05 | 17 | 96 | 3 | 3.10.200.10 | |
| Domain | Carbonic_anhydrase_a | 8.49e-05 | 17 | 96 | 3 | IPR001148 | |
| Domain | TAAR_fam | 5.40e-04 | 7 | 96 | 2 | IPR009132 | |
| Domain | ANION_EXCHANGER_2 | 5.40e-04 | 7 | 96 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 5.40e-04 | 7 | 96 | 2 | PS00219 | |
| Domain | BTK | 9.19e-04 | 9 | 96 | 2 | SM00107 | |
| Domain | Znf_Btk_motif | 9.19e-04 | 9 | 96 | 2 | IPR001562 | |
| Domain | Band3_cytoplasmic_dom | 9.19e-04 | 9 | 96 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 9.19e-04 | 9 | 96 | 2 | PF07565 | |
| Domain | - | 9.19e-04 | 9 | 96 | 2 | 3.40.1100.10 | |
| Domain | BTK | 9.19e-04 | 9 | 96 | 2 | PF00779 | |
| Domain | ZF_BTK | 9.19e-04 | 9 | 96 | 2 | PS51113 | |
| Domain | IG_LIKE | KIR2DS2 IGFBPL1 CD200R1 HEPACAM CD86 BTN2A3P KIR2DL1 KIR2DL3 KIR2DS5 | 9.54e-04 | 491 | 96 | 9 | PS50835 |
| Domain | Ig-like_dom | KIR2DS2 IGFBPL1 CD200R1 HEPACAM CD86 BTN2A3P KIR2DL1 KIR2DL3 KIR2DS5 | 1.13e-03 | 503 | 96 | 9 | IPR007110 |
| Domain | HCO3_cotransp | 1.15e-03 | 10 | 96 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.15e-03 | 10 | 96 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 1.15e-03 | 10 | 96 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.15e-03 | 10 | 96 | 2 | IPR003020 | |
| Domain | IG | KIR2DS2 IGFBPL1 CD200R1 HEPACAM CD86 KIR2DL1 KIR2DL3 KIR2DS5 | 1.47e-03 | 421 | 96 | 8 | SM00409 |
| Domain | Ig_sub | KIR2DS2 IGFBPL1 CD200R1 HEPACAM CD86 KIR2DL1 KIR2DL3 KIR2DS5 | 1.47e-03 | 421 | 96 | 8 | IPR003599 |
| Domain | RasGAP | 2.29e-03 | 14 | 96 | 2 | SM00323 | |
| Domain | RasGAP_CS | 2.29e-03 | 14 | 96 | 2 | IPR023152 | |
| Domain | GPCR_Rhodpsn_7TM | HTR1D TAAR2 TAAR5 OR10AG1 ADRA2B GPR174 OR6C2 RXFP2 OR56A3 CCR6 | 2.32e-03 | 670 | 96 | 10 | IPR017452 |
| Domain | 7tm_1 | HTR1D TAAR2 TAAR5 OR10AG1 ADRA2B GPR174 OR6C2 RXFP2 OR56A3 CCR6 | 2.50e-03 | 677 | 96 | 10 | PF00001 |
| Domain | RasGAP | 2.63e-03 | 15 | 96 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 2.63e-03 | 15 | 96 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 2.63e-03 | 15 | 96 | 2 | PS50018 | |
| Domain | 7TM_GPCR_Srsx | 2.66e-03 | 112 | 96 | 4 | SM01381 | |
| Domain | G_PROTEIN_RECEP_F1_1 | HTR1D TAAR2 TAAR5 OR10AG1 ADRA2B GPR174 OR6C2 RXFP2 OR56A3 CCR6 | 2.72e-03 | 685 | 96 | 10 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | HTR1D TAAR2 TAAR5 OR10AG1 ADRA2B GPR174 OR6C2 RXFP2 OR56A3 CCR6 | 2.90e-03 | 691 | 96 | 10 | PS50262 |
| Domain | GPCR_Rhodpsn | HTR1D TAAR2 TAAR5 OR10AG1 ADRA2B GPR174 OR6C2 RXFP2 OR56A3 CCR6 | 2.93e-03 | 692 | 96 | 10 | IPR000276 |
| Domain | - | 2.99e-03 | 16 | 96 | 2 | 1.10.506.10 | |
| Domain | Ig-like_fold | KIR2DS2 IGFBPL1 CD200R1 HEPACAM CD86 BTN2A3P KIR2DL1 KIR2DL3 KIR2DS5 IL4R | 3.38e-03 | 706 | 96 | 10 | IPR013783 |
| Domain | Aa_trans | 3.38e-03 | 17 | 96 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 3.38e-03 | 17 | 96 | 2 | IPR013057 | |
| Domain | RasGAP_dom | 3.79e-03 | 18 | 96 | 2 | IPR001936 | |
| Pathway | REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE | 2.39e-05 | 12 | 69 | 3 | M671 | |
| Pathway | REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE | 2.39e-05 | 12 | 69 | 3 | MM14574 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 5.11e-05 | 42 | 69 | 4 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 5.11e-05 | 42 | 69 | 4 | MM14971 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.59e-04 | 238 | 69 | 7 | MM15076 | |
| Pathway | KEGG_NITROGEN_METABOLISM | 1.85e-04 | 23 | 69 | 3 | M4629 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.09e-04 | 249 | 69 | 7 | M5988 | |
| Pubmed | 4.29e-09 | 8 | 99 | 4 | 18681957 | ||
| Pubmed | 7.70e-09 | 9 | 99 | 4 | 7749980 | ||
| Pubmed | 1.28e-08 | 10 | 99 | 4 | 12559621 | ||
| Pubmed | 2.01e-08 | 11 | 99 | 4 | 18830515 | ||
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 2.01e-08 | 11 | 99 | 4 | 19664392 | |
| Pubmed | 3.00e-08 | 12 | 99 | 4 | 20371502 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 3.00e-08 | 12 | 99 | 4 | 19181658 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 3.00e-08 | 12 | 99 | 4 | 17490516 | |
| Pubmed | 3.00e-08 | 12 | 99 | 4 | 20137308 | ||
| Pubmed | 3.00e-08 | 12 | 99 | 4 | 19936734 | ||
| Pubmed | 4.33e-08 | 13 | 99 | 4 | 18687225 | ||
| Pubmed | 4.33e-08 | 13 | 99 | 4 | 19934297 | ||
| Pubmed | 4.33e-08 | 13 | 99 | 4 | 19120281 | ||
| Pubmed | 5.12e-08 | 35 | 99 | 5 | 19683555 | ||
| Pubmed | 6.05e-08 | 14 | 99 | 4 | 19875891 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 6.05e-08 | 14 | 99 | 4 | 19421224 | |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 6.05e-08 | 14 | 99 | 4 | 15896204 | |
| Pubmed | 8.23e-08 | 15 | 99 | 4 | 20082646 | ||
| Pubmed | 8.23e-08 | 15 | 99 | 4 | 19926642 | ||
| Pubmed | 8.23e-08 | 15 | 99 | 4 | 19850842 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 8.23e-08 | 15 | 99 | 4 | 20207982 | |
| Pubmed | 8.23e-08 | 15 | 99 | 4 | 19493232 | ||
| Pubmed | 8.23e-08 | 15 | 99 | 4 | 20356536 | ||
| Pubmed | 8.23e-08 | 15 | 99 | 4 | 20643584 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 8.23e-08 | 15 | 99 | 4 | 17498266 | |
| Pubmed | 8.23e-08 | 15 | 99 | 4 | 19326408 | ||
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 19897003 | ||
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 19000141 | ||
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 20670355 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 1.09e-07 | 16 | 99 | 4 | 19527230 | |
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 20652381 | ||
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 18668235 | ||
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 19279038 | ||
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 17868255 | ||
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 18643961 | ||
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 19309280 | ||
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 20331834 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 1.09e-07 | 16 | 99 | 4 | 16403292 | |
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 20210919 | ||
| Pubmed | 1.43e-07 | 17 | 99 | 4 | 20173784 | ||
| Pubmed | 1.43e-07 | 17 | 99 | 4 | 20173792 | ||
| Pubmed | 1.43e-07 | 17 | 99 | 4 | 20483367 | ||
| Pubmed | 1.43e-07 | 17 | 99 | 4 | 19968064 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 1.43e-07 | 17 | 99 | 4 | 19218127 | |
| Pubmed | 1.43e-07 | 17 | 99 | 4 | 19169284 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 1.43e-07 | 17 | 99 | 4 | 20878400 | |
| Pubmed | 1.43e-07 | 17 | 99 | 4 | 20650299 | ||
| Pubmed | 1.43e-07 | 17 | 99 | 4 | 19450876 | ||
| Pubmed | 1.43e-07 | 17 | 99 | 4 | 19761533 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 1.83e-07 | 18 | 99 | 4 | 19630074 | |
| Pubmed | 1.83e-07 | 18 | 99 | 4 | 20519398 | ||
| Pubmed | 1.83e-07 | 18 | 99 | 4 | 20200544 | ||
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 1.83e-07 | 18 | 99 | 4 | 19046302 | |
| Pubmed | 1.83e-07 | 18 | 99 | 4 | 19846535 | ||
| Pubmed | 1.83e-07 | 18 | 99 | 4 | 20580654 | ||
| Pubmed | 1.83e-07 | 18 | 99 | 4 | 20210918 | ||
| Pubmed | 2.23e-07 | 5 | 99 | 3 | 16112031 | ||
| Pubmed | 2.23e-07 | 5 | 99 | 3 | 7716543 | ||
| Pubmed | 2.23e-07 | 5 | 99 | 3 | 18755860 | ||
| Pubmed | Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual. | 2.23e-07 | 5 | 99 | 3 | 10424431 | |
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | 2.32e-07 | 19 | 99 | 4 | 18571006 | |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 2.32e-07 | 19 | 99 | 4 | 18778326 | |
| Pubmed | 2.32e-07 | 19 | 99 | 4 | 20600442 | ||
| Pubmed | 2.32e-07 | 19 | 99 | 4 | 18848853 | ||
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 2.89e-07 | 20 | 99 | 4 | 20193031 | |
| Pubmed | 3.56e-07 | 21 | 99 | 4 | 19861144 | ||
| Pubmed | 4.34e-07 | 22 | 99 | 4 | 20492596 | ||
| Pubmed | 7.77e-07 | 7 | 99 | 3 | 14607943 | ||
| Pubmed | Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. | 7.77e-07 | 7 | 99 | 3 | 11169255 | |
| Pubmed | 1.24e-06 | 8 | 99 | 3 | 20820888 | ||
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | 1.39e-06 | 29 | 99 | 4 | 20082482 | |
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 1.86e-06 | 9 | 99 | 3 | 8662091 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | LEMD3 LPCAT4 IDH1 CAV1 CAV2 FOCAD SLC30A5 XPO5 SLC25A2 MACO1 FURIN HERC1 SLC33A1 CDH16 | 1.90e-06 | 1061 | 99 | 14 | 33845483 |
| Pubmed | A systematic quantification of carbonic anhydrase transcripts in the mouse digestive system. | 4.83e-06 | 12 | 99 | 3 | 17362527 | |
| Pubmed | 4.83e-06 | 12 | 99 | 3 | 25173106 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 19489269 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 18945962 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 9361015 | ||
| Pubmed | Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures. | 8.02e-06 | 2 | 99 | 2 | 23881097 | |
| Pubmed | Association of the CAV1-CAV2 locus with normal-tension glaucoma in Chinese and Japanese. | 8.02e-06 | 2 | 99 | 2 | 32162426 | |
| Pubmed | High expressions of caveolins on the proliferating bile ductules in primary biliary cirrhosis. | 8.02e-06 | 2 | 99 | 2 | 15968725 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 11316799 | ||
| Pubmed | Hepatic overexpression of caveolins increases bile salt secretion in mice. | 8.02e-06 | 2 | 99 | 2 | 14647059 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 11063570 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 23743525 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 9801158 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24034151 | ||
| Pubmed | Expression of KIR2DL3 and KIR2DS2 natural killer receptors in exercise. | 8.02e-06 | 2 | 99 | 2 | 21165439 | |
| Pubmed | The presence of KIR2DS5 confers protection against adult immune thrombocytopenia. | 8.02e-06 | 2 | 99 | 2 | 24571473 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 10218480 | ||
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 8.02e-06 | 2 | 99 | 2 | 11448776 | |
| Pubmed | Stromal Caveolin-1 and Caveolin-2 Expression in Primary Tumors and Lymph Node Metastases. | 8.02e-06 | 2 | 99 | 2 | 29850392 | |
| Pubmed | The scaffolding domain of caveolin 2 is responsible for its Golgi localization in Caco-2 cells. | 8.02e-06 | 2 | 99 | 2 | 12414992 | |
| Pubmed | Caveolin-1 and -2 in airway epithelium: expression and in situ association as detected by FRET-CLSM. | 8.02e-06 | 2 | 99 | 2 | 16904002 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 18158964 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21543742 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 17671707 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 12388077 | ||
| Pubmed | The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. | 8.02e-06 | 2 | 99 | 2 | 1360410 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21321670 | ||
| Interaction | KIR3DP1 interactions | 3.32e-07 | 4 | 89 | 3 | int:KIR3DP1 | |
| Cytoband | 19q13.4 | 2.70e-05 | 79 | 99 | 4 | 19q13.4 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 8.00e-07 | 18 | 75 | 4 | 620 | |
| GeneFamily | Solute carriers | SLC4A8 SLC4A1 SLC32A1 SLC30A5 SLC22A16 SLC25A2 SLC33A1 SLC38A6 SLC26A6 SLC22A31 | 5.17e-06 | 395 | 75 | 10 | 752 |
| GeneFamily | Carbonic anhydrases | 5.35e-05 | 18 | 75 | 3 | 460 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.24e-04 | 394 | 75 | 8 | 471 | |
| GeneFamily | Trace amine receptors | 6.00e-04 | 9 | 75 | 2 | 188 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 7.48e-04 | 10 | 75 | 2 | 830 | |
| GeneFamily | Ubiquitin specific peptidases | 1.62e-03 | 56 | 75 | 3 | 366 | |
| GeneFamily | Integrator complex | 1.72e-03 | 15 | 75 | 2 | 1366 | |
| Coexpression | NOUSHMEHR_GBM_SOMATIC_MUTATED | 3.81e-06 | 9 | 95 | 3 | M2089 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 178 | 95 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-06 | 189 | 95 | 6 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-06 | 189 | 95 | 6 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.48e-06 | 200 | 95 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-05 | 154 | 95 | 5 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | COVID-19-lung-RBC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.67e-05 | 175 | 95 | 5 | 4c35292ad2ac712ba7516f27dd6eac6ba8fdd163 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.77e-05 | 176 | 95 | 5 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.09e-05 | 179 | 95 | 5 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 179 | 95 | 5 | d78eacf47847a50888dd16c35bed9b7afc80010f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.78e-05 | 185 | 95 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 4.78e-05 | 185 | 95 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 187 | 95 | 5 | a178b1fed80a0bf83aedb6262493ee17374734b5 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 187 | 95 | 5 | e60cbccf5842f25123fd34b9475759b7424b32e9 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-9|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.03e-05 | 187 | 95 | 5 | f002ff1a7cb7577f28acff008bc2aa561ac1a4bf | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 187 | 95 | 5 | 2b8eda2812be0be68a6f01aa4038925d3d5b1e65 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 189 | 95 | 5 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 5.29e-05 | 189 | 95 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-05 | 190 | 95 | 5 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 191 | 95 | 5 | 9fc674a58f20b47255e4457d5195c8cff17b0414 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 191 | 95 | 5 | c379a499dabf3c9ed80f47adbb2d949821c5b053 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.84e-05 | 193 | 95 | 5 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | distal-2-Hematologic-Myeloid_Dendritic_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.99e-05 | 194 | 95 | 5 | 6881cfe12837a32e598535a564e4c31d4846167b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 195 | 95 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Dendritic_Cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.26e-05 | 100 | 95 | 4 | bb7bd11e28be830f381144d4a6f29a86da59d9fa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.29e-05 | 196 | 95 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 198 | 95 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 198 | 95 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 198 | 95 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.75e-05 | 199 | 95 | 5 | 565404c155dfac57c020a8f2d09cbf756da20ffd | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.75e-05 | 199 | 95 | 5 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | Biopsy_Other_PF-Epithelial-Transitional_AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.92e-05 | 200 | 95 | 5 | 1ba6327851aa61e9a1f1fe1671bc27929d93ac74 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 68b0f987c4fb8078675475f4f1e71302f832ef69 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 1b527bebbca1ef8c52449e40beb9358e37494e04 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 6.92e-05 | 200 | 95 | 5 | c2df917900872453ea17a39928e39d071a6d3339 | |
| Computational | Intermediate filaments. | 3.83e-05 | 75 | 55 | 5 | MODULE_154 | |
| Computational | Intermediate filaments and keratins. | 5.23e-05 | 80 | 55 | 5 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 5.23e-05 | 80 | 55 | 5 | MODULE_297 | |
| Drug | apraclonidine | 8.68e-07 | 18 | 96 | 4 | CID000002216 | |
| Drug | orthanilamide | 1.44e-06 | 6 | 96 | 3 | CID000072894 | |
| Drug | sulfonamide | 3.22e-06 | 54 | 96 | 5 | CID000005333 | |
| Drug | aminozolamide | 4.01e-06 | 8 | 96 | 3 | CID000093505 | |
| Drug | L-662,583 | 4.01e-06 | 8 | 96 | 3 | CID003082977 | |
| Drug | L-643,799 | 4.01e-06 | 8 | 96 | 3 | CID000121595 | |
| Drug | sezolamide | 4.01e-06 | 8 | 96 | 3 | CID000060692 | |
| Drug | methazolamide | 4.13e-06 | 26 | 96 | 4 | CID000004100 | |
| Drug | benzolamide | 5.62e-06 | 28 | 96 | 4 | CID000018794 | |
| Drug | qassa | 5.99e-06 | 9 | 96 | 3 | CID003082191 | |
| Drug | 6-hydroxyethoxzolamide | 5.99e-06 | 9 | 96 | 3 | CID000094706 | |
| Drug | Prontosil | 8.53e-06 | 10 | 96 | 3 | CID000066895 | |
| Drug | metanilamide | 8.53e-06 | 10 | 96 | 3 | CID000007377 | |
| Drug | 1,3-benzenedisulfonamide | 8.53e-06 | 10 | 96 | 3 | CID003090044 | |
| Drug | AC1L8MM4 | 8.53e-06 | 10 | 96 | 3 | CID000429016 | |
| Drug | benzenesulfonamide | 1.11e-05 | 33 | 96 | 4 | CID000007370 | |
| Drug | Cl 13850 | 1.17e-05 | 11 | 96 | 3 | CID000159459 | |
| Drug | cobalt phosphate | 1.17e-05 | 11 | 96 | 3 | CID000061615 | |
| Drug | Tio-urasin | 1.17e-05 | 11 | 96 | 3 | CID000084724 | |
| Drug | sodium bicarbonate | 1.54e-05 | 74 | 96 | 5 | CID000010340 | |
| Drug | hydroflumethiazide | 1.55e-05 | 12 | 96 | 3 | CID000003647 | |
| Drug | mafenide acetate | 2.01e-05 | 13 | 96 | 3 | CID000003998 | |
| Drug | chlorzolamide | 2.01e-05 | 13 | 96 | 3 | CID000165323 | |
| Drug | Fg 400 | 2.01e-05 | 13 | 96 | 3 | CID000012443 | |
| Drug | bendrofluazide | 2.18e-05 | 39 | 96 | 4 | CID000002315 | |
| Drug | cobalt;sulfide | 2.56e-05 | 14 | 96 | 3 | CID000159453 | |
| Drug | brimonidine | 3.19e-05 | 86 | 96 | 5 | CID000002435 | |
| Drug | sodium | CACNA1C SLC4A8 CA13 BCKDHB IDH1 GABBR2 SLC4A1 SLC32A1 SLC22A16 SACS SLC25A2 FURIN CA2 CA7 | 4.07e-05 | 944 | 96 | 14 | CID000000923 |
| Drug | metolazone | 4.73e-05 | 17 | 96 | 3 | CID000004170 | |
| Drug | betaxolol | 5.01e-05 | 48 | 96 | 4 | CID000002369 | |
| Drug | racemic timolol | 6.37e-05 | 51 | 96 | 4 | CID000005478 | |
| Drug | sulthiame | 6.70e-05 | 19 | 96 | 3 | CID000005356 | |
| Drug | cyanate | 8.58e-05 | 55 | 96 | 4 | CID000000540 | |
| Drug | AC1LCVB4 | 9.14e-05 | 21 | 96 | 3 | CID000656627 | |
| Drug | methyl paraoxon | 9.14e-05 | 21 | 96 | 3 | CID000013708 | |
| Drug | CGP 51176 | 1.05e-04 | 4 | 96 | 2 | CID005310935 | |
| Drug | 3-azanylpropylphosphonous acid | 1.05e-04 | 4 | 96 | 2 | CID009989268 | |
| Drug | I-7B | 1.05e-04 | 4 | 96 | 2 | CID000067136 | |
| Drug | CGP56433 | 1.05e-04 | 4 | 96 | 2 | CID000132966 | |
| Drug | AABSSN | 1.06e-04 | 22 | 96 | 3 | CID005464134 | |
| Drug | carbamoyl phosphate | 1.18e-04 | 113 | 96 | 5 | CID000000278 | |
| Drug | dichlorphenamide | 1.21e-04 | 23 | 96 | 3 | CID000003038 | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.30e-04 | 184 | 96 | 6 | 3945_DN | |
| Drug | potassium cyanate | 1.38e-04 | 24 | 96 | 3 | CID011378442 | |
| Drug | trans-1,2-diphenylethylene | 1.38e-04 | 117 | 96 | 5 | CID000011502 | |
| Drug | furosemide | 1.55e-04 | 272 | 96 | 7 | CID000003440 | |
| Drug | quisqualamine | 1.74e-04 | 5 | 96 | 2 | CID003085372 | |
| Drug | 4-ABPA | 1.74e-04 | 5 | 96 | 2 | CID000001726 | |
| Drug | Fluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 7348_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; PC3; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 7150_UP | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; PC3; HT_HG-U133A | 2.05e-04 | 200 | 96 | 6 | 6334_DN | |
| Disease | level of killer cell immunoglobulin-like receptor 2DS2 in blood serum | 2.69e-05 | 3 | 89 | 2 | OBA_2042107 | |
| Disease | Diffuse Scleroderma | 8.94e-05 | 5 | 89 | 2 | C1258104 | |
| Disease | CREST Syndrome | 1.34e-04 | 6 | 89 | 2 | C0206138 | |
| Disease | Scleroderma, Limited | 1.34e-04 | 6 | 89 | 2 | C0748540 | |
| Disease | complement factor D measurement | 1.84e-04 | 93 | 89 | 4 | EFO_0020283 | |
| Disease | Secondary Open Angle Glaucoma | 5.82e-04 | 12 | 89 | 2 | C0271148 | |
| Disease | Glaucoma, Open-Angle | 5.82e-04 | 12 | 89 | 2 | C0017612 | |
| Disease | Glaucoma, Primary Open Angle | 6.87e-04 | 13 | 89 | 2 | C0339573 | |
| Disease | high grade glioma (biomarker_via_orthology) | 9.21e-04 | 15 | 89 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 9.21e-04 | 15 | 89 | 2 | EFO_0801746 | |
| Disease | anemia (implicated_via_orthology) | 9.21e-04 | 15 | 89 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | vital capacity | 1.22e-03 | 1236 | 89 | 11 | EFO_0004312 | |
| Disease | multiple sclerosis (is_implicated_in) | 1.42e-03 | 73 | 89 | 3 | DOID:2377 (is_implicated_in) | |
| Disease | Graves disease | 1.91e-03 | 81 | 89 | 3 | EFO_0004237 | |
| Disease | primary open angle glaucoma (is_implicated_in) | 2.18e-03 | 23 | 89 | 2 | DOID:1070 (is_implicated_in) | |
| Disease | Anhedonia | 2.38e-03 | 24 | 89 | 2 | C0178417 | |
| Disease | systemic scleroderma (is_implicated_in) | 2.38e-03 | 24 | 89 | 2 | DOID:418 (is_implicated_in) | |
| Disease | open-angle glaucoma | 2.71e-03 | 191 | 89 | 4 | EFO_0004190 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IVVAVPLCVWELQKL | 26 | Q9NVA4 | |
| VALWLVDPLTVKECV | 466 | O00400 | |
| KWILSLEEPLCQVGI | 406 | Q96KV6 | |
| VLTPCRKDVLVVTPW | 76 | P16442 | |
| VQLTPLVIDCVKTVW | 36 | Q2NKJ3 | |
| PQVTAESRCKLLSWL | 126 | P22674 | |
| IICLAVLWVVKSTPA | 841 | P02730 | |
| CWRKTIITSPESLNL | 101 | Q9NR80 | |
| LPRSKIICLVVWGLS | 161 | P51684 | |
| PRRIKCIILTVWLIA | 126 | P18089 | |
| VPPLLESVTWIVLKQ | 201 | Q8N1Q1 | |
| IPWITAVLPTVIICV | 246 | P42081 | |
| ILSFLHIWAVVPCIK | 121 | Q03135 | |
| KWTLAVETPACTLEL | 376 | Q8TBY9 | |
| VKYWICLALIEPITS | 461 | Q8WWK9 | |
| NEPIIRTATVWKTLC | 36 | O43374 | |
| PLLKISCSDTWVIEQ | 181 | Q9NZP2 | |
| NEPIIRTATVWKTLC | 36 | C9J798 | |
| GPLVKSEETVILQCW | 36 | P43631 | |
| IIPLAPISKSLWTCS | 41 | Q9NVM9 | |
| ELTPLVGLIRWCVKA | 236 | Q96N11 | |
| RWIQPSASCDKILVI | 746 | Q9Y2U8 | |
| VCASLISITKLEWNP | 176 | Q8N682 | |
| VRKTISHLPIQLWCV | 531 | P56975 | |
| TIIPWDVDTICKSVI | 306 | P21953 | |
| IWECLPGKVNITVVA | 716 | Q6IE37 | |
| VKPSWVILSVQCGTL | 71 | Q6ZW49 | |
| LVCPSIEELKNVWLP | 796 | Q504Q3 | |
| VCIQLIIASWTITIP | 131 | Q8NH19 | |
| KVLWLTASQPCSIVD | 251 | Q643R3 | |
| WIDKCRPNLLITEST | 191 | Q5TA45 | |
| GPLVKSEETVILQCW | 36 | P43628 | |
| WLTTIEKRLVNCEPI | 5516 | Q03001 | |
| LRTLCIEVWPVLAVI | 2296 | Q15751 | |
| TERGVCLPTVSLWIL | 116 | Q8N5G2 | |
| WIQKPDSVCSLVELS | 666 | Q86VH2 | |
| WDTPLIVIIVLAGSC | 746 | O95206 | |
| CWLIRLCISIVVLPK | 651 | Q6AI08 | |
| CEVRAVPTPVITWRK | 176 | Q8WX77 | |
| IVPCAISWLFRLIEE | 491 | Q9ULI4 | |
| CPPIALRNLIIITWE | 61 | Q8TD46 | |
| IITWEIILRGQPSCT | 71 | Q8TD46 | |
| PWPVDIVISLECQKI | 806 | Q96RT8 | |
| TPLLIVLYCTWKTVL | 196 | Q9BXC1 | |
| GPLVKSEETVILQCW | 36 | Q14953 | |
| AIICKNIPRLVSGWV | 111 | O75874 | |
| LWPESISVVRCVELF | 351 | P24394 | |
| CWRLVPTLDLDKVVS | 341 | O95352 | |
| EKCTRSPLLTQLWAT | 206 | Q5W0U4 | |
| ACISIVEWKPFEIII | 116 | Q13936 | |
| WTTVAPQRKCIIDIL | 441 | P09958 | |
| IVWAISICISIPPLF | 161 | P28221 | |
| RLVITPLTDRCWLTL | 1136 | Q0VDD8 | |
| ILICWQAVDPLRRTV | 611 | O75899 | |
| FLLVTLVTVCACWKP | 251 | Q14CZ8 | |
| SESVTWIVLREPICI | 206 | P43166 | |
| CSSWSLSPVILIKVV | 1046 | Q9Y4K1 | |
| LSPVILIKVVRGCWI | 1051 | Q9Y4K1 | |
| VWLTCLKRPLVVIHE | 311 | P54198 | |
| TIWKSVTDVIIAPLC | 131 | P51636 | |
| TTWIIPFISPILIIC | 516 | P60507 | |
| WVPCIVLGLVLSSEE | 26 | A6NKX4 | |
| VLQLLWTSCPILPEK | 3696 | Q9NZJ4 | |
| GPLVKSEETVILQCW | 36 | P43626 | |
| LWLLCVSVPQALPKA | 6 | O75309 | |
| VVCIRSTWNALSPKL | 641 | Q5VW36 | |
| CWLPLATLIDEKVLI | 276 | O14830 | |
| LIKTCPVWLQLSLGQ | 56 | Q8TB24 | |
| TQAWKCIRVEALPIL | 51 | Q5TCS8 | |
| LVLPLSTIRSVESCW | 86 | O14804 | |
| TVTVPFILCCWVLPE | 276 | Q86VW1 | |
| LSLIYTVLEVCWKLP | 246 | Q9BXS9 | |
| DSVTCPLEVALLWKV | 76 | Q9P1W9 | |
| DLFTKWIVILPLCDV | 166 | Q9NXP7 | |
| WIVILPLCDVSASEV | 171 | Q9NXP7 | |
| ALVVIIKKWSIPCPL | 206 | Q8IZM9 | |
| TCDLLPLKAWLDTIT | 221 | Q9H156 | |
| SDAICWIPVFVVKIL | 646 | Q8WXD0 | |
| VSTPLIIKWLENISC | 146 | Q8WVM0 | |
| ETCPSLILWEKRTAL | 1151 | Q9NT68 | |
| VLCLTVIPKVLTIFW | 76 | Q8NH54 | |
| EKCILVITWIQHLIP | 116 | Q9UL46 | |
| TCLVLLWVIKASPAA | 961 | Q2Y0W8 | |
| ICLWLVVFPVDCIKS | 221 | Q9BXI2 | |
| VTPSLLPTVWVRLLC | 311 | Q7Z7M1 | |
| SLTTPPLLECVTWIV | 196 | P00918 | |
| PLLECVTWIVLKEPI | 201 | P00918 | |
| TALGTPLWIKATVLC | 26 | P58418 | |
| TLDTLVQRPIISICW | 336 | Q9NRJ4 | |
| TEPHCIIINLSTWII | 111 | Q70EL2 | |
| RTTSQLCWPLLKQVL | 1046 | Q9HAV4 | |
| VQNWLVEVPIVSPIC | 936 | Q9UQG0 | |
| EVEVNCKWILPILTQ | 211 | O60813 | |
| VLACSLPQVFLKPWI | 46 | Q8N816 | |
| TIPVIKRLLLLCWSV | 156 | Q9P1P5 | |
| WVIPALKQIREICSL | 566 | O00507 | |
| STKIWFVIELCEPIQ | 346 | Q9UBS9 | |
| VLLLCPWVIVLSVTT | 246 | Q8TAD4 | |
| TLAITIWRLKPSADC | 851 | Q6UXY8 | |
| KSWSIIATAVLLPCA | 241 | Q9H598 | |
| GPLEVLCITIWRTLE | 236 | Q6PP77 | |
| IPTCLATWKIAIAAE | 1901 | O60293 | |
| CRRVLSWVPVLVIVL | 16 | Q96MV8 | |
| TCKSVTPEWVLQDLI | 761 | Q86W25 |